Go to Bing homepage
Go to Bing homepage

Saved!

NEW YORK, Oct. 15, 2018 /PRNewswire/ -- A new wave of gene therapy treatments to revolutionize treatment of …

RELATED: Spark slides on hemophilia A data, aims for phase 3 Spark generated investor enthusiasm last …

Novartis’ CAR-T product Kymriah became the first gene-modified cell therapy approved by the FDA in August 2017, with …

This month Caspian became among the first patients in the country to receive a new gene-therapy treatment called Luxturna. The therapy entails …